Insider · CIK 0001743774

JOHNSON KENNETH ERLAND

Reports to the SEC for 2 companies · CHICAGO, IL

sec.gov

Transactions

Companies

Filings

CIK

0001743774

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−15.5K sh	$3.56	−$55.1K	346,288
2025-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−25.8K sh	$3.56	−$92K	320,446
2025-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−12.4K sh	$3.61	−$44.8K	361,764
2024-01-31	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+175K sh	—	—	446,860
2024-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−15.1K sh	$2.46	−$37.2K	373,036
2024-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−10.7K sh	$2.66	−$28.6K	388,167
2024-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−12.4K sh	$2.24	−$27.8K	398,914
2023-01-31	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+100K sh	—	—	269,783
2023-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−3,393 sh	$1.24	−$4,207.32	411,314
2023-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−11K sh	$1.26	−$13.9K	414,707
2023-01-03	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−12.4K sh	$1.12	−$13.9K	425,736
2022-01-31	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−2,307 sh	$2.11	−$4,867.77	438,136
2022-01-29	XERSXeris Biopharma Holdings, Inc.F Tax Payment	See Remarks	FTax Payment	−7,497 sh	$2.11	−$15.8K	440,443
2022-01-03	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+75K sh	—	—	165,865
2021-10-05	XERIS PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−11.3K sh	—	—	78,333
2021-10-05	XERIS PHARMACEUTICALS INCD Disposition to Issuer	See Remarks	DDisposition to Issuer	−78.3K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−33.7K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−5,280 sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−39.6K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−21.4K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−32.5K sh	—	—	0
2021-10-05	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−100K sh	—	—	0
2021-10-05	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+11.3K sh	—	—	11,250
2021-10-05	XERSXeris Biopharma Holdings, Inc.A Award	See Remarks	AAward	+78.3K sh	—	—	89,583
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+33.7K sh	—	—	33,686
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+5,280 sh	—	—	5,280
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+39.6K sh	—	—	39,633
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+21.4K sh	—	—	21,401
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+32.5K sh	—	—	32,500
2021-10-05	XERSXeris Biopharma Holdings, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2021-01-29	XERIS PHARMACEUTICALS INCA Award	See Remarks	AAward	+65K sh	—	—	91,890
2020-08-14	XERIS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	See Remarks	AAward	+100K sh	—	—	100,000
2020-06-30	XERIS PHARMACEUTICALS INCA Award	See Remarks	AAward	+775 sh	$2.26	+$1,751.5	26,890
2020-02-14	XERIS PHARMACEUTICALS INCP Purchase	See Remarks	PPurchase	+2,410 sh	$4.15	+$10K	6,115
2020-01-31	XERIS PHARMACEUTICALS INCA Award	See Remarks	AAward	+20K sh	—	—	26,115
2019-12-31	XERIS PHARMACEUTICALS INCA Award	See Remarks	AAward	+286 sh	$5.99	+$1,713.14	3,705
2019-07-01	XERIS PHARMACEUTICALS INCA Award	See Remarks	AAward	+174 sh	$9.72	+$1,691.28	3,419
2019-02-19	XERIS PHARMACEUTICALS INCP Purchase	See Remarks	PPurchase	+1,000 sh	$10.00	+$10K	3,245
2019-01-31	XERIS PHARMACEUTICALS INCStock Option (right to buy)A Award	See Remarks	AAward	+32.5K sh	—	—	32,500
2018-06-25	XERIS PHARMACEUTICALS INCC Conversion	See Remarks	CConversion	+2,245 sh	—	—	2,245
2018-06-25	XERIS PHARMACEUTICALS INCSeries C Preferred StockC Conversion	See Remarks	CConversion	−4,000 sh	—	—	0

Recent filings

Accepted (ET)
Feb 34
JOHNSON KENNETH ERLAND0001867096-25-000023
SEC(opens sec.gov)
Jan 74
JOHNSON KENNETH ERLAND0001867096-25-000013
SEC(opens sec.gov)
Aug 94
JOHNSON KENNETH ERLAND0001867096-24-000169
SEC(opens sec.gov)
Jan 314
JOHNSON KENNETH ERLAND0001867096-24-000016
SEC(opens sec.gov)
Feb 14
JOHNSON KENNETH ERLAND0001867096-23-000019
SEC(opens sec.gov)
Jan 54
JOHNSON KENNETH ERLAND0001867096-22-000010
SEC(opens sec.gov)
Oct 54
JOHNSON KENNETH ERLAND0000899243-21-039246
SEC(opens sec.gov)

Companies

Address

C/O XERIS BIOPHARMA HOLDINGS, INC. 1375 WEST FULTON STREET, SUITE 1300

CHICAGO, IL, 60607